SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001206774-10-001040
Filing Date
2010-04-27
Accepted
2010-04-26 17:56:42
Documents
14
Period of Report
2010-06-11
Effectiveness Date
2010-04-27

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT regeneron_def14a.htm DEF 14A 877084
2 regeneron_def14a1x1x1.jpg GRAPHIC 12080
3 regeneron_def14a1x1x2.jpg GRAPHIC 5817
4 regeneron_def14a1x2x1.jpg GRAPHIC 6832
5 regeneron_def14a1x6x1.jpg GRAPHIC 8004
6 regeneron_def14a1x6x2.jpg GRAPHIC 9728
7 regeneron_def14a1x7x1.jpg GRAPHIC 9173
8 regeneron_def14a1x7x2.jpg GRAPHIC 9143
9 regeneron_def14a1x8x1.jpg GRAPHIC 8900
10 regeneron_def14a1x8x2.jpg GRAPHIC 9451
11 regeneron_def14a1x8x3.jpg GRAPHIC 9375
12 regeneron_def14a1x9x1.jpg GRAPHIC 8892
13 regeneron_def14a1x9x2.jpg GRAPHIC 9155
14 regeneron_def14a1x9x3.jpg GRAPHIC 9322
  Complete submission text file 0001206774-10-001040.txt   1039950
Mailing Address
Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000
REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19034 | Film No.: 10771267
SIC: 2834 Pharmaceutical Preparations